Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVERSAL: Atorvastatin vs Pravastatin in Coronary Atherosclerosis
NCT00380939Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in coronary arteriosclerosis, sponsored by Pfizer. Started Apr 1999; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NCT00380939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00380939.